AVENUE SOLUTIONS for VIROPHARMA INCORPORATED
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
S. 3187, Food and Drug Administration Safety and Innovation Act -issues related to bioequivalence for locally-acting drugs; H.R. 5651, Food and Drug Administration Reform Act of 2012 - issues related to bioequivalence for locally-acting drugs; H.R. 3988, Generic Drug and Biosimilar User Fee Act of 2012 - issues related to bioequivalence for locally-acting drugs; Senate working drafts of PDUFA (Prescription Drug User Fee Act) Reauthorization - issues related to bioequivalence for locally-acting drugs
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH MACDONALD BARNETT | — |
| TRACY SPICER | — |
| AMY TEJRAL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.